Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.
Alzheimer's disease (AD) is diagnosed based upon medical history, neuropsychiatric examination, cerebrospinal fluid analysis, extensive laboratory analyses and cerebral imaging. Diagnosis is time consuming and labour intensive. Parkinson's disease (PD) is mainly diagnosed on clinical groun...
Main Authors: | Jan-Philipp Bach, Maike Gold, David Mengel, Akira Hattesohl, Dirk Lubbe, Severin Schmid, Björn Tackenberg, Jürgen Rieke, Sasidhar Maddula, Jörg Ingo Baumbach, Christoph Nell, Tobias Boeselt, Joan Michelis, Judith Alferink, Michael Heneka, Wolfgang Oertel, Frank Jessen, Sabina Janciauskiene, Claus Vogelmeier, Richard Dodel, Andreas Rembert Koczulla |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4500505?pdf=render |
Similar Items
-
Comparison of two devices and two breathing patterns for exhaled breath condensate sampling.
by: Eva-Maria Hüttmann, et al.
Published: (2011-01-01) -
Exhaled breath analysis for lung cancer detection using ion mobility spectrometry.
by: Hiroshi Handa, et al.
Published: (2014-01-01) -
Feasibility and safety of whole-body vibration therapy in intensive care patients
by: Peter Alter, et al.
Published: (2017-04-01) -
Validity and Usability of Physical Activity Monitoring in Patients with Chronic Obstructive Pulmonary Disease (COPD).
by: Tobias Boeselt, et al.
Published: (2016-01-01) -
Therapy with plasma purified alpha1-antitrypsin (Prolastin®) induces time-dependent changes in plasma levels of MMP-9 and MPO.
by: Janine Koepke, et al.
Published: (2015-01-01)